Tr3st or Stano

[FreakJay]

I am putting together a dmz cycle at 32/32/32/32/32/32 and wanted to know which to choose and the dosage, thanks.

 

[Mystere3]

Trest is better in terms of gains.

 

[FreakJay]

Trest is better in terms of gains.

do you know a dosage ratio? and should i get an AI

 

[Mystere3]

50-100 mg, yes.

 

[g0hardorgohom]

do you know a dosage ratio? and should i get an AI

Trest is better at combatting lethargy and libido loss too.

50/75/75/75/75/75 is great dosing protocol. One bottle of TR3ST is enough. Discount code TR3ST15 gives you 15% off at nutri-verse.com

AI like Formeron is always good to have on hand!

 

[g0hardorgohom]

Can someone tell me the point of an AI i never really researched one

Some compounds like testosterone, methandienone (dbol) and trestolone aromatizes to estrogen. Estrogen can cause unwanted side effects like gynecomastia, loss of libido and bloating. AI's keep that kind of side effects at bay.Trust me, gyno is not a nice thing to have.Formeron should be sufficient for trest.

 

[FreakJay]

Some compounds like testosterone, methandienone (dbol) and trestolone aromatizes to estrogen. Estrogen can cause unwanted side effects like gynecomastia, loss of libido and bloating. AI's keep that kind of side effects at bay.Trust me, gyno is not a nice thing to have.Formeron should be sufficient for trest.

I thought that was the point of having clomid included in pct? I also have a pct that has an anti estrogen involved in it would that be ok ?

 

[g0hardorgohom]

I thought that was the point of having clomid included in pct? I also have a pct that has an anti estrogen involved in it would that be ok ?

No, no, no. Clomid is not an AI, it's a SERM.

You'll need an AI on cycle as well if you're using heavily aromatizing compounds. Just trust me here and buy a bottle of Formeron, Formasurge or some other transdermal formestane product. Aromasin or arimidex are options also but you can't get those from supplement stores.

 

[FreakJay]

No, no, no. Clomid is not an AI, it's a SERM.

You'll need an AI on cycle as well if you're using heavily aromatizing compounds. Just trust me here and buy a bottle of Formeron, Formasurge or some other transdermal formestane product. Aromasin or arimidex are options also but you can't get those from supplement stores.

i trust you im just confused lol.. im gonna order some formeron and tr3st rn.. is there any coupons ? and do you know a dosage for the formeron or when to take it specifically? Thanks alot man!

 

[Olympus Labs]

i trust you im just confused lol.. im gonna order some formeron and tr3st rn.. is there any coupons ? and do you know a dosage for the formeron or when to take it specifically? Thanks alot man!

TR3ST15 @ Nutri-Verse till Tuesday I believe.

Brings the price down to like $64.00 for 3 grams

 

[g0hardorgohom]

i trust you im just confused lol.. im gonna order some formeron and tr3st rn.. is there any coupons ? and do you know a dosage for the formeron or when to take it specifically? Thanks alot man!

Like OL said, TR3ST15 gives you 15% off at Nutriverse.

2 pumps of Formeron per day is probably good dose with trest.

 

[FreakJay]

Thank you guys.. and g0hard do you take it as soon as you start cycle or if you feel as if it is needed? Thanks!

 

[stankyleg]

Tr3st is gonna smoke stano in terms of gains. Here's everything you could ever wanna know about trest. I copied and pasted this btw.

"methyl nor testosterone (ment)

Androgenic 650
Anabolic 2,300
Standard Testosterone propionate
Chemical Names 19-norandrost-4-en-3-one-17beta-ol 17beta-hydroxy-estr-4-en-3-one
Estrogenic Activity low
Progestational Activity moderate

Description:
MENT, short for methylnortestosterone (acetate), is a synthetic anabolic steroid derived from nandrolone. This agent is also called trestolone acetate, although not as commonly. The trivial name methylnortestosterone is vague, and can also be applied to other steroids. In this case the "methyl" in the name, which is commonly associated with (-17 alpha alkylated androgens like methyltestosterone, methandrostenolone, or oxymetholone, is referring to a modification at (-7. This gives MENT a considerably different appearance than 17methylnoretestosterone (Orgasteron). Of most obvious significance is its method of use. Although perhaps possessing a moderate level of oral bioavailability, this nandrolone derivative was not designed for oral administration. It is much more effective when administered to the body directly, by injection, implant, or transdermal gel. In character, MENT is a strongly anabolic steroid, which is accompanied by moderate androgenic and estrogenic properties.
General steroid potency is usually increased with 7methylation, a trait well illustrated with MENT. When methylation increases steroid potency it is usually due to one or a couple of things, most notably increased resistance to hepatic metabolism (breakdown) or reduced affinity for constrictive binding proteins. In the case of MENT, we see a steroid with relatively fast metabolic breakdown, but no binding to SHBG (Sex HormoneBinding Globulin).593 Therefore, reduced binding to serum proteins seems to be partly responsible for making MENT a more potent steroid. When assayed in 1963, scientists reported an anabolic effect that was between 3.5 and 23 times greater than testosterone, while being only 3-6 times more androgenic.594 595 When investigated in primates in 1998, it was shown to have 10 times more anabolic potency than testosterone,_ with only 2 times the stimulatory action on the prostate.596 Its relative androgen receptor binding affinity was investigated a year later, and provided further explanation for the strong anabolic effect of this steroid. Here, MENT was shown to bind the androgen receptor more strongly than testosterone, nandrolone, or dihydrotestosterone.

MENT (methylnortestosterone acetate) was first described in 1963.598 The early 1960's were part of the heyday of anabolic steroid development, with new compounds being introduced into the journals almost every week. Like a great many of the effective steroids studied during this era, however, MENT didn't make its way to becoming a commercial drug product. For about four decades it sat gathering dust on the bookshelves, next to many other effective but anonymous compounds. Historically, lack of early financial support has been a death sentence for anabolic steroids. If a company isn't there in the beginning to spend the millions necessary to develop it into an 'actual prescription product, it isn't going to go anywhere later on. The money simply wasn't there for MENT in the 1960s, and it died. For a long time this agent remained a "nothing" in the world of steroids.
But things changed for MENT around the turn of the century, in a very dramatic fashion. On October 30, 2000, international drug giant Schering AG made a pubHc announcement that it had entered into a partnership to research, develop, and market methylnortestosterone acetate for both male contraceptive and hormone replacement use. This followed several years of sporadic but positive studies on this agent. The ball was set in motion, and this old steroid, which scientists had ignored for over thirty years, was suddenly amidst a hotbed of new research and speculation, the likes of which it had never seen before. In their press release, Schering AG makes promise of a new androgen that offers the anabolic and endocrine benefits of an injectable testosterone, but with less prostate growth, and more patient comfort. In other words, Schering is saying that MENT looks to be an easier to administer and equally useful steroid as testosterone, without the same issues concerning androgenicity.
The principle attraction Schering has to MENT is probably not necessarily its potency, but its ability to duplicate the positive effects of testosterone on muscle mass and male sexual function while minimizing stimulatory action on the prostate. Prostate cancer and benign prostate enlargement are very common problems among males in the U.S., and both diseases are fueled at least partly by androgens. This has led to a great deal of caution when it comes to androgen replacement therapy in older men. Although the medical data is still inconclusive in this regard, many physicians fear that the androgenicity of testosterone may lead to ill effects. After all, increases in PSA values with testosterone use in older men are well documented.599 Perhaps MENT is being introduced to alleviate this concern. Noticing the lower relative androgenicity of MENT, researchers concluded over a decade ago that it might be a far better option for hormone replacement therapy. To quote the researchers from the NY Center for Biomedical Research exactly, "We conclude that the use of MENT instead ofT for androgen replacement therapy could have health-promoting effects by reducing the occurrence of prostate disease."600 This is quite a statement, especially when we remember it concerns the use of a synthetic anabolic steroid.
Looking a little more closely at some of the recent studies conducted on MENT, we see a general trend of success and relative safety. Perhaps the most noteworthy to examine is the multinational clinical study that was conducted between 2002 and 2003.601 It involved the use of MENT implants as long-term contraceptives in males. In this experiment, thirty-six men were enrolled in three separate clinics residing in Germany, Chile, and the Dominical Republic (12 men at each). The study protocols itself called for the use of the implants for 6, 9, or 12 months, and required periodic examinations to measure their effects and potential risks. Three different dosages were used, which consisted of administering one, two, or four implants at the onset of the investigation. Each implant is designed to deliver about 400mcg of steroid per day, which equates to daily doses of .4mg, .8mg, or 1.6mg of steroid. The release rate is slowly reduced as the implant loses surface area, however, reaching approximately 200mcg per day by the one-year mark.
The results of the clinical trial were very promising. Four MENT implants (1.6mg/day) suppressed spermatogenesis with similar effectiveness as testosterone implants, testosterone enanthate injections, and testosterone undecanoate injections (all of which have been investigated successfully as contraceptives). MENT was able to produce azoospermia in 82°;0 of treated subjects, a figure that was actually higher than reported with 200 mg of testosterone enanthate per week (which produced azoospermia in 65-660/0 of normal male subjects by 6 months).As far as negative side effects, they were few.Two subjects noted increases in blood pressure that went outside the normal range, and one was forced to discontinue the study because of it (though no ill effect was noted). Otherwise, there was generally just a very small rise in systolic pressure (+4.8), and no significant changes in lipids (including cholesterol and triglycerides) or PSA values. Furthermore, prostate volume was slightly reduced (not increased) in all groups. Liver enzymes were increased slightly, but stayed within the normal range in all subjects. The mean time to the recovery of normal sperm production after discontinuance was 3 months, similar to that reported in a 1990 World Heath Organization study with 200 mg weekly of testosterone enanthate. Overall, MENT performed admirably, with a very notable (acceptable) level of effect, and minimal side effects. And what is more, the drug may be effective when being implanted as infrequently as once per year.
Another study of interest examined the ability of MENT implants to restore sexual behavior and function in hypogonadal (low testosterone) men.602 This, of course, is one of the principle objectives of androgen replacement therapy. This investigation took place in two clinics, one based in Ireland and the other Hong Kong. Twenty men participated in total, 10 at each location. The study was a double crossover investigation comparing the effects of testosterone enanthate (200 mg every 3 weeks) to that of two MENT implants (delivering .8mg of drug per day).This means that each of the twenty men had an opportunity to try both drugs, which were taken on two separate occasions between washoLit periods. Only minor differences in response were noted between MENT and conventional androgen replacement therapy, and both drugs were effective in restoring sexual behavior and erection frequency. MENT, at a dosage of 2 implants delivering approximately .8mg of drug per day, proved to be an effective option for androgen replacement therapy.
If Schering does market this drug as an implant, it will be impractical to use for bodybuilding purposes. At best it will need to be broken down and made into an injectable somehow. The clinical study discussed above used implants containing about 140 mg of steroid each. Given the same in a production drug, more than one implant will be needed for a workable cycle. There is some investigation into its use as an oral,603 which does seem feasible (although not ideal from a cost effectiveness standpoint). The key to this steroid's success with bodybuilders will really be the development of a commercial injectable.This will likely follow the release of Schering's product; perhaps even precede it. The raw powder is already available from suppliers overseas, so it should not take long for some veterinary or underground manufacturer to perceive value in this new agent. An acetate version will probably be closely followed by a slower-acting MENT ester, perhaps even something basic like MENT cypionate or MENT enanthate.

 

[g0hardorgohom]

Thank you guys.. and g0hard do you take it as soon as you start cycle or if you feel as if it is needed? Thanks!

I'd probably take one pump per day since the day 1 and up it to 2 or even 3 pumps/day if needed.

 

[FreakJay]

I'd probably take one pump per day since the day 1 and up it to 2 or even 3 pumps/day if needed.

does it matter where you apply it ? im thinking im gonna do forearms

 

[FreakJay]

Tr3st is gonna smoke stano in terms of gains. Here's everything you could ever wanna know about trest. I copied and pasted this btw.

"methyl nor testosterone (ment)

Androgenic 650
Anabolic 2,300
Standard Testosterone propionate
Chemical Names 19-norandrost-4-en-3-one-17beta-ol 17beta-hydroxy-estr-4-en-3-one
Estrogenic Activity low
Progestational Activity moderate

Description:
MENT, short for methylnortestosterone (acetate), is a synthetic anabolic steroid derived from nandrolone. This agent is also called trestolone acetate, although not as commonly. The trivial name methylnortestosterone is vague, and can also be applied to other steroids. In this case the "methyl" in the name, which is commonly associated with (-17 alpha alkylated androgens like methyltestosterone, methandrostenolone, or oxymetholone, is referring to a modification at (-7. This gives MENT a considerably different appearance than 17methylnoretestosterone (Orgasteron). Of most obvious significance is its method of use. Although perhaps possessing a moderate level of oral bioavailability, this nandrolone derivative was not designed for oral administration. It is much more effective when administered to the body directly, by injection, implant, or transdermal gel. In character, MENT is a strongly anabolic steroid, which is accompanied by moderate androgenic and estrogenic properties.
General steroid potency is usually increased with 7methylation, a trait well illustrated with MENT. When methylation increases steroid potency it is usually due to one or a couple of things, most notably increased resistance to hepatic metabolism (breakdown) or reduced affinity for constrictive binding proteins. In the case of MENT, we see a steroid with relatively fast metabolic breakdown, but no binding to SHBG (Sex HormoneBinding Globulin).593 Therefore, reduced binding to serum proteins seems to be partly responsible for making MENT a more potent steroid. When assayed in 1963, scientists reported an anabolic effect that was between 3.5 and 23 times greater than testosterone, while being only 3-6 times more androgenic.594 595 When investigated in primates in 1998, it was shown to have 10 times more anabolic potency than testosterone,_ with only 2 times the stimulatory action on the prostate.596 Its relative androgen receptor binding affinity was investigated a year later, and provided further explanation for the strong anabolic effect of this steroid. Here, MENT was shown to bind the androgen receptor more strongly than testosterone, nandrolone, or dihydrotestosterone.

MENT (methylnortestosterone acetate) was first described in 1963.598 The early 1960's were part of the heyday of anabolic steroid development, with new compounds being introduced into the journals almost every week. Like a great many of the effective steroids studied during this era, however, MENT didn't make its way to becoming a commercial drug product. For about four decades it sat gathering dust on the bookshelves, next to many other effective but anonymous compounds. Historically, lack of early financial support has been a death sentence for anabolic steroids. If a company isn't there in the beginning to spend the millions necessary to develop it into an 'actual prescription product, it isn't going to go anywhere later on. The money simply wasn't there for MENT in the 1960s, and it died. For a long time this agent remained a "nothing" in the world of steroids.
But things changed for MENT around the turn of the century, in a very dramatic fashion. On October 30, 2000, international drug giant Schering AG made a pubHc announcement that it had entered into a partnership to research, develop, and market methylnortestosterone acetate for both male contraceptive and hormone replacement use. This followed several years of sporadic but positive studies on this agent. The ball was set in motion, and this old steroid, which scientists had ignored for over thirty years, was suddenly amidst a hotbed of new research and speculation, the likes of which it had never seen before. In their press release, Schering AG makes promise of a new androgen that offers the anabolic and endocrine benefits of an injectable testosterone, but with less prostate growth, and more patient comfort. In other words, Schering is saying that MENT looks to be an easier to administer and equally useful steroid as testosterone, without the same issues concerning androgenicity.
The principle attraction Schering has to MENT is probably not necessarily its potency, but its ability to duplicate the positive effects of testosterone on muscle mass and male sexual function while minimizing stimulatory action on the prostate. Prostate cancer and benign prostate enlargement are very common problems among males in the U.S., and both diseases are fueled at least partly by androgens. This has led to a great deal of caution when it comes to androgen replacement therapy in older men. Although the medical data is still inconclusive in this regard, many physicians fear that the androgenicity of testosterone may lead to ill effects. After all, increases in PSA values with testosterone use in older men are well documented.599 Perhaps MENT is being introduced to alleviate this concern. Noticing the lower relative androgenicity of MENT, researchers concluded over a decade ago that it might be a far better option for hormone replacement therapy. To quote the researchers from the NY Center for Biomedical Research exactly, "We conclude that the use of MENT instead ofT for androgen replacement therapy could have health-promoting effects by reducing the occurrence of prostate disease."600 This is quite a statement, especially when we remember it concerns the use of a synthetic anabolic steroid.
Looking a little more closely at some of the recent studies conducted on MENT, we see a general trend of success and relative safety. Perhaps the most noteworthy to examine is the multinational clinical study that was conducted between 2002 and 2003.601 It involved the use of MENT implants as long-term contraceptives in males. In this experiment, thirty-six men were enrolled in three separate clinics residing in Germany, Chile, and the Dominical Republic (12 men at each). The study protocols itself called for the use of the implants for 6, 9, or 12 months, and required periodic examinations to measure their effects and potential risks. Three different dosages were used, which consisted of administering one, two, or four implants at the onset of the investigation. Each implant is designed to deliver about 400mcg of steroid per day, which equates to daily doses of .4mg, .8mg, or 1.6mg of steroid. The release rate is slowly reduced as the implant loses surface area, however, reaching approximately 200mcg per day by the one-year mark.
The results of the clinical trial were very promising. Four MENT implants (1.6mg/day) suppressed spermatogenesis with similar effectiveness as testosterone implants, testosterone enanthate injections, and testosterone undecanoate injections (all of which have been investigated successfully as contraceptives). MENT was able to produce azoospermia in 82°;0 of treated subjects, a figure that was actually higher than reported with 200 mg of testosterone enanthate per week (which produced azoospermia in 65-660/0 of normal male subjects by 6 months).As far as negative side effects, they were few.Two subjects noted increases in blood pressure that went outside the normal range, and one was forced to discontinue the study because of it (though no ill effect was noted). Otherwise, there was generally just a very small rise in systolic pressure (+4.8), and no significant changes in lipids (including cholesterol and triglycerides) or PSA values. Furthermore, prostate volume was slightly reduced (not increased) in all groups. Liver enzymes were increased slightly, but stayed within the normal range in all subjects. The mean time to the recovery of normal sperm production after discontinuance was 3 months, similar to that reported in a 1990 World Heath Organization study with 200 mg weekly of testosterone enanthate. Overall, MENT performed admirably, with a very notable (acceptable) level of effect, and minimal side effects. And what is more, the drug may be effective when being implanted as infrequently as once per year.
Another study of interest examined the ability of MENT implants to restore sexual behavior and function in hypogonadal (low testosterone) men.602 This, of course, is one of the principle objectives of androgen replacement therapy. This investigation took place in two clinics, one based in Ireland and the other Hong Kong. Twenty men participated in total, 10 at each location. The study was a double crossover investigation comparing the effects of testosterone enanthate (200 mg every 3 weeks) to that of two MENT implants (delivering .8mg of drug per day).This means that each of the twenty men had an opportunity to try both drugs, which were taken on two separate occasions between washoLit periods. Only minor differences in response were noted between MENT and conventional androgen replacement therapy, and both drugs were effective in restoring sexual behavior and erection frequency. MENT, at a dosage of 2 implants delivering approximately .8mg of drug per day, proved to be an effective option for androgen replacement therapy.
If Schering does market this drug as an implant, it will be impractical to use for bodybuilding purposes. At best it will need to be broken down and made into an injectable somehow. The clinical study discussed above used implants containing about 140 mg of steroid each. Given the same in a production drug, more than one implant will be needed for a workable cycle. There is some investigation into its use as an oral,603 which does seem feasible (although not ideal from a cost effectiveness standpoint). The key to this steroid's success with bodybuilders will really be the development of a commercial injectable.This will likely follow the release of Schering's product; perhaps even precede it. The raw powder is already available from suppliers overseas, so it should not take long for some veterinary or underground manufacturer to perceive value in this new agent. An acetate version will probably be closely followed by a slower-acting MENT ester, perhaps even something basic like MENT cypionate or MENT enanthate.

im all focused on the gains so this just perfect for me thank very much

 

[Mystere3]

Apply formeron to shoulders/chest.

 

[Mystere3]

Keep in mind the info he's posting is for IM not oral trest.

 

[FreakJay]

Keep in mind the info he's posting is for IM not oral trest.

Thanks for pointing that out. Didnt catch on to that